{
    "clinical_study": {
        "@rank": "25120", 
        "arm_group": [
            {
                "arm_group_label": "Stem cell", 
                "arm_group_type": "Experimental", 
                "description": "Autologous bone marrow mononuclear cells intrathecal and intramuscular transplantation"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "No cell transplantation was done"
            }
        ], 
        "brief_summary": {
            "textblock": "The effect of autologous bone marrow mononuclear cells on duration of survival in\n      Amyotrophic Lateral Sclerosis patients."
        }, 
        "brief_title": "Stem Cell Therapy for Amyotrophic Lateral Sclerosis", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Amyotrophic Lateral Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Amyotrophic Lateral Sclerosis", 
                "Sclerosis", 
                "Motor Neuron Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Survival duration in Amyotrophic Lateral Sclerosis patients who received cellular\n      transplantation was compared to patients who did not receive cellular transplantation.\n      Kaplan-Meier survival analysis was used for this comparison."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with the diagnoses of definite amyotrophic lateral sclerosis.\n\n          -  Clear information about date of onset of symptoms, documented contact information and\n             follow up information\n\n        Exclusion Criteria:\n\n          -  Patients with diagnoses of Progressive Lateral sclerosis, Progressive bulbar plasy,\n             Progressive spinal muscular atrophy, Progressive muscular atrophy,\n             monomelicamyotrophy or madras motor neuron disease.\n\n          -  patients with co-morbidities like presence of acute infections such as Human\n             Immunodeficiency Virus/Hepatitis B Virus/Hepatitis C Virus, malignancies, bleeding\n             tendencies, renal failure, severe liver dysfunction and other acute medical\n             conditions such as respiratory infection and pyrexia."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "76 Years", 
            "minimum_age": "26 Years"
        }, 
        "enrollment": {
            "#text": "57", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01984814", 
            "org_study_id": "NGBSI-04"
        }, 
        "intervention": {
            "arm_group_label": "Stem cell", 
            "description": "Autologous bone marrow derived mononuclear cells were administered via intrathecal and intramuscular routes.", 
            "intervention_name": "Stem cell", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 14, 2013", 
        "link": {
            "description": "The Amyotrophic lateral sclerosis association encourages scientific research to find a cure for ALS and heightens awareness of the nature of the disease.", 
            "url": "http://www.alsa.org/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Mumbai", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "400071"
                }, 
                "name": "Neurogen brain and spine institute"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Autologous Bone Marrow Mononuclear Cell Transplantation on the Survival Duration in Amyotrophic Lateral Sclerosis - A Retrospective Control Study", 
        "overall_official": {
            "affiliation": "Neurogen Brain and Spine Institute", 
            "last_name": "Alok K Sharma, MS,MCh", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Indian Council of Medical Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Duration of survival", 
            "safety_issue": "Yes", 
            "time_frame": "56 months"
        }, 
        "reference": [
            {
                "PMID": "23860588", 
                "citation": "Chi\u00f2 A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118-30. doi: 10.1159/000351153. Epub 2013 Jul 11."
            }, 
            {
                "PMID": "19012065", 
                "citation": "Deda H, Inci MC, K\u00fcrek\u00e7i AE, Sav A, Kayihan K, Ozg\u00fcn E, Ust\u00fcnsoy GE, Kocabay S. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy. 2009;11(1):18-25. doi: 10.1080/14653240802549470."
            }, 
            {
                "PMID": "22415951", 
                "citation": "Blanquer M, Moraleda JM, Iniesta F, G\u00f3mez-Espuch J, Meca-Lallana J, Villaverde R, P\u00e9rez-Espejo M\u00c1, Ru\u00edz-L\u00f3pez FJ, Garc\u00eda Santos JM, Bleda P, Izura V, S\u00e1ez M, De Mingo P, Vivancos L, Carles R, Jim\u00e9nez J, Hern\u00e1ndez J, Guardiola J, Del Rio ST, Ant\u00fanez C, De la Rosa P, Majado MJ, S\u00e1nchez-Salinas A, L\u00f3pez J, Mart\u00ednez-Lage JF, Mart\u00ednez S. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study. Stem Cells. 2012 Jun;30(6):1277-85. doi: 10.1002/stem.1080."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01984814"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Neurogen Brain and Spine Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Neurogen Brain and Spine Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2008", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}